Oxford Nanopore Technologies and Plasmidsaurus Announce Strategic Collaboration to Advance Plasmid Sequencing
23 Julio 2024 - 9:12AM
Business Wire
The teams aim to redefine plasmid sequencing
with nanopore technology and global accessibility
Oxford Nanopore Technologies, the company behind a new
generation of molecular sensing technology based on nanopores, and
Plasmidsaurus, the LA-based company that introduced overnight
whole-plasmid sequencing, today announced an expanded, multi-year
contract and a collaboration aimed at transforming the plasmid
sequencing market through the application of nanopore
technology.
Plasmidsaurus has pioneered a rapid, whole-plasmid sequencing
service based on nanopore sequencing. This service sets new
standards for quality and speed, delivering overnight results and
richer datasets that unlock more accurate, comprehensive and
reliable insights for researchers and industry professionals around
the world. Founded in 2021, Plasmidsaurus has since opened nine
labs in three countries and is expanding its global network of 660
dropboxes and labs in key biotech hubs, including new locations in
the US, Europe, and Asia. Plasmidsaurus became an Oxford Nanopore
customer in 2021.
Traditional plasmid sequencing methods, such as Sanger, are
limited by short read lengths and primer dependency and are
confounded by GC-rich or repetitive DNA. Oxford Nanopore technology
removes these obstacles with real-time, long-read sequencing that
does not need and has no trouble with GC-rich or repetitive DNA.
The result is a more efficient and cost-effective solution that
saves months of work lost to faulty plasmids.
"By collaborating with Plasmidsaurus, we are advancing the
fields of synthetic biology and biotechnology through the unique
capabilities of nanopore technology that are not possible with
legacy methods," said Gordon Sanghera, CEO of Oxford Nanopore. "Our
joint efforts will drive significant market growth and deliver
best-in-class sequencing services to a global audience."
As strategic partners going forward, Oxford Nanopore and
Plasmidsaurus will also co-develop new technologies, reagents, and
applications beyond plasmid sequencing, including microbial and
gene therapy use cases, to best meet evolving market needs.
"Oxford Nanopore makes the most advanced sequencing technology
in the world, and it has been rewarding to identify and implement
such a transformative use case." said Mark Budde, CEO of
Plasmidsaurus. "We are thrilled to work directly as partners to
develop technology to solve other daily needs of biotech
researchers around the globe."
To find out more about Oxford Nanopore and plasmid sequencing,
visit:
https://nanoporetech.com/resource-centre/workflow-plasmid-sequencing-best-practice-workflow
About Plasmidsaurus
Plasmidsaurus is on a mission to accelerate new cures and
promote a healthier planet by unlocking new levels of productivity
in scientists using DNA tools to bring their ideas to life. The
company’s DNA sequencing services are used daily by thousands of
innovators, including Nobel prize winners, dynamic biotech
startups, pharmaceutical companies, research labs, and DIY
biohackers and has been cited in more than 800 publications to
date. Plasmidsaurus’s global network of labs operates day and night
to enable world-changing discoveries. For more, visit:
https://plasmidsaurus.com/
About Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest
benefits to society through enabling the analysis of anything, by
anyone, anywhere. The company has developed a new generation of
nanopore-based sensing technology for real-time, high-performance,
accessible, and scalable analysis of DNA and RNA. The technology is
used in more than 120 countries to understand the biology of humans
and diseases such as cancer, plants, animals, bacteria, viruses,
and whole environments. Oxford Nanopore Technologies products are
intended for molecular biology applications and are not intended
for diagnostic purposes. For more, visit:
https://nanoporetech.com/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240723583604/en/
Media@nanoporetech.com